Vitamin D deficiency predisposes to adherent-invasive escherichia coli-induced barrier dysfunction and experimental colonic injury

Inflammatory Bowel Diseases

Volumn 21, Issue 2, 2015, Pages 297-306

  Assa, Amit ^a   Vong, Linda ^a   Pinnell, Lee J ^a   Rautava, Jaana ^a   Avitzur, Naama ^a   Johnson Henry, Kathene C ^a   Sherman, Philip M ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adherent invasive E. coli; Colonization; Crohn's disease; Environmental factors; Microbiota

Indexed keywords

DEXTRAN SULFATE; TIGHT JUNCTION PROTEIN; VITAMIN D; CALCITRIOL; MESSENGER RNA;

ADHERENT INVASIVE ESCHERICHIA COLI; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELL GROWTH; COLITIS; COLON INJURY; CONTROLLED STUDY; DIET; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ELECTRIC RESISTANCE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TEMPERATURE; INTESTINAL EPITHELIAL BARRIER; INTESTINE MUCOSA PERMEABILITY; MICROBIAL COMMUNITY; MICROBIOME; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VITAMIN D DEFICIENCY; ANIMAL; APOPTOSIS; BACTERIUM ADHERENCE; C57BL MOUSE; CACO 2 CELL LINE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; COMPLICATION; CROHN DISEASE; DISEASE MODEL; DRUG EFFECTS; ELECTRIC CONDUCTIVITY; ENZYME IMMUNOASSAY; ESCHERICHIA COLI INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE; GASTROINTESTINAL TRACT; GENETICS; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BACTERIAL ADHESION; BLOTTING, WESTERN; CACO-2 CELLS; CALCITRIOL; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELLS, CULTURED; COLITIS; CROHN DISEASE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; ELECTRIC CONDUCTIVITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GASTROINTESTINAL TRACT; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VITAMIN D DEFICIENCY;

EID: 84927728108     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000282     Document Type: Article

References (56)

1. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.
2. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421.
3. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998;115:1405-1413.
4. Eaves-Pyles T, Allen CA, Taormina J, et al. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008;298:397-409.
5. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80-93.
6. Martinez-Medina M, Aldeguer X, Lopez-Siles M, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis. 2009;15:872-882.
7. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest. 2007;87:1042-1054.
8. Negroni A, Costanzo M, Vitali R, et al. Characterization of adherentinvasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:913-924.
9. Drouet M, Vignal C, Singer E, et al. AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation. Inflamm Bowel Dis. 2012;18:1923-1931.
10. Miquel S, Peyretaillade E, Claret L, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS One. 2010;5:e12714.
11. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007;117:1566-1574.
12. Carvalho FA, Barnich N, Sivignon A, et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med. 2009;206:2179-2189.
13. Ossa JC, Ho NK, Wine E, et al. Adherent-invasive Escherichia coli blocks interferon-g-induced signal transducer and activator of transcription (STAT)-1 in human intestinal epithelial cells. Cell Microbiol. 2013;15: 446-457.
14. Dreux N, Denizot J, Martinez-Medina M, et al. Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog. 2013;9:e1003141.
15. Soderholm JD, Olaison G, Peterson KH, et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut. 2002;50:307-313.
16. Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut. 2006;55:342-347.
17. Arnott ID, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol. 2000;35: 1163-1169.
18. Wine E, Ossa JC, Gray-Owen SD, et al. Adherent-invasive Escherichia coli target the epithelial barrier. Gut.Microbes. 2010;1:80-84.
19. Blanck S, Aberra F, Vitamin D Deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci. 2013;58:1698-1702.
20. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012;142:482-489.
21. Ardizzone S, Cassinotti A, Bevilacqua M, et al. Vitamin D and inflammatory bowel disease. Vitam Horm. 2011;86:367-377.
22. Xue LN, Xu KQ, Zhang W, et al. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: A meta-analysis. Inflamm Bowel Dis. 2013;19:54-60.
23. von Essen MR, Kongsbak M, Schjerling P, et al. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010;11:344-349.
24. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med. 2010;88:441-450.
25. Cantorna MT. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc. 2010;69:286-289.
26. Mathieu C, Gysemans C, Giulietti A, et al. Vitamin D and diabetes. Diabetologia. 2005;48:1247-1257.
27. Cantorna MT. Vitamin D and multiple sclerosis: An update. Nutr Rev. 2008;66:S135-S138.
28. Froicu M, Weaver V, Wynn TA, et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003;17:2386-2392.
29. Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007;8:5.
30. Kong J, Zhang Z, Musch MW, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294:208-216.
31. Zhao H, Zhang H, Wu H, et al. Protective role of 1, 25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol. 2012;12:57.
32. Lagishetty V, Misharin AV, Liu NQ, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151:2423-2432.
33. Peterson MD, Mooseker MS. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci. 1992;102:581-600.
34. Zareie M, Riff J, Donato K, et al. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell Microbiol. 2005;7:1782-1797.
35. Assa A, Vong L, Pinnell LJ, et al. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014; 210:1296-1305.
36. Johnson-Henry K, Hagen KE, Gordonpour M, et al. Surface layer extracts from Lactobacillus helveticus inhibits enterohemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells. Cell Microbiol. 2007;9:356-367.
37. Cantey J, Hosterman D. Characterization of colonization of the rabbit gastrointestinal tract by Escherichia coli RDEC-1. Infect Immun. 1979; 26:1099-1103.
38. Wine E, Shen-Tu G, Gareau MG, et al. Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attachingeffacing lesions. Am J Pathol. 2010;177:1320-1332.
39. Savidge TC, Newman P, Pothoulakis C, et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology. 2007;132:1344-1358.
40. Bachetti De Gregoris T, Aldred N, Clare AS, et al. Improvement of phylum- And class-specific primers for real-time PCR quantification of bacterial taxa. J Microbiol Methods. 2011;86:351-356.
41. Manichanh C, Borruel N, Casellas F, et al. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9:599-608.
42. Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: Association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011;35:308-316.
43. Jørgensen SP, Hvas CL, Agnholt J, et al. Active Crohn's disease is associated with low vitamin D levels. J Crohns Colitis. 2013;7:e407-e413.
44. Levin AD, Wadhera V, Leach ST, et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci. 2011;56:830-836.
45. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008;4:80-90.
46. Ghoreishi M, Bach P, Obst J, et al. Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol. J Immunol. 2009;182:6071-6078.
47. Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005; 2:308-315.
48. Jeffery LE, Burke F, Mura M, et al. 1, 25-dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;3:5458-5467.
49. Wang TT, Dabbas B, Laperriere D, et al. Direct and indirect induction by 1, 25- dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285:2227-2231.
50. Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009;4:1151-1165.
51. Fujita H, Sugimoto K, Inatomi S, et al. Tight junction proteins claudin-2 and 12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol Biol Cell. 2008;19:1912-1921.
52. Carvalho FA, Barnich N, Sauvanet P, et al. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis. 2008;14:1051-1060.
53. Barnich N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli and Crohn's disease. Curr Opin Gastroenterol. 2007;23:16-20.
54. Mankertz J, Amasheh M, Krug S, et al. TNFa up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3- kinase signaling. Cell Tissue Res. 2009;336:67-77.
55. Griffiths NJ, Bradley CJ, Heyderman RS, et al. IFN-gamma amplifies NFkappaB-dependent Neisseria meningitidis invasion of epithelial cells via specific upregulation of CEA-related cell adhesion molecule 1. Cell Microbiol. 2007;9:2968-2983.
56. Martinez-Medina M, Denizot J, Dreux N, et al. Western diet induces dysbiosis with increased E. coli CEABAC10 mice, alters host barrier function favoring AIEC colonization. Gut. 2014;63:116-124.